DAPASUG-M

Dapagliflozin 10mg + Metformin 500mg ER is a combination oral medication used to manage type 2 diabetes mellitus. Dapagliflozin, an SGLT2 inhibitor, works by reducing glucose reabsorption in the kidneys, promoting glucose excretion through urine, and improving blood sugar control. Metformin, a biguanide, reduces hepatic glucose production and improves insulin sensitivity, enhancing glycemic control. The extended-release (ER) formulation ensures a steady release of Metformin, reducing gastrointestinal side effects and providing convenient once-daily dosing. This combination is ideal for patients who require dual action therapy to manage blood sugar levels effectively.